Literature DB >> 28551790

Connexin 43 and Mitochondria in Cardiovascular Health and Disease.

Kerstin Boengler1, Rainer Schulz2.   

Abstract

Connexin 43 (Cx43) is the major connexin protein in ventricular cardiomyocytes. Six Cx43 proteins assemble into so-called hemichannels at the sarcolemma and opposing hemichannels form gap junctions, which allow the passage of small molecules and electrical current flow between adjacent cells. Apart from its localization at the plasma membrane, Cx43 is also present in cardiomyocyte mitochondria, where it is important for mitochondrial function in terms of oxygen consumption and potassium fluxes. The expression of gap junctional and mitochondrial Cx43 is altered under several pathophysiological conditions among them are hypertension, hypertrophy, hypercholesterolemia, ischemia/reperfusion injury, post-infarction remodeling, and heart failure. The present review will focus on the role of Cx43 in cardiovascular diseases and will highlight the importance of mitochondrial Cx43 in cardioprotection.

Entities:  

Keywords:  Cardioprotection; Connexin 43; Ischemia/Reperfusion; Mitochondria; Phosphorylation

Mesh:

Substances:

Year:  2017        PMID: 28551790     DOI: 10.1007/978-3-319-55330-6_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  31 in total

Review 1.  Therapeutic strategies targeting connexins.

Authors:  Dale W Laird; Paul D Lampe
Journal:  Nat Rev Drug Discov       Date:  2018-10-12       Impact factor: 84.694

2.  Alpha-lipoic acid potentiates the anti-arrhythmic effects of ischemic postconditioning in the setting of cardiac ischemia/reperfusion injury in diabetic rats.

Authors:  Sanaz Gholami; Behnaz Mokhtari; Reza Badalzadeh
Journal:  J Diabetes Metab Disord       Date:  2022-03-31

3.  Anti-Arrhythmic Effects of Linalool via Cx43 Expression in a Rat Model of Myocardial Infarction.

Authors:  Jianlin Ke; Canzhan Zhu; Yuanyuan Zhang; Wenlong Zhang
Journal:  Front Pharmacol       Date:  2020-06-25       Impact factor: 5.810

4.  A role for connexin-43 in Duchenne muscular dystrophy cardiomyopathy.

Authors:  Robin M Shaw; Jeffrey E Saffitz
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

5.  Cannabinoid Receptor Agonist Inhibits Atrial Electrical Remodeling in a Tachypaced Ex Vivo Rat Model.

Authors:  Danielle I Lee; Michael Murninkas; Sigal Elyagon; Yoram Etzion; Hope D Anderson
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 6.  Cellular mechanisms of connexin-based inherited diseases.

Authors:  Dale W Laird; Paul D Lampe
Journal:  Trends Cell Biol       Date:  2021-08-21       Impact factor: 20.808

Review 7.  Mitochondrial ion channels as targets for cardioprotection.

Authors:  Derek J Hausenloy; Rainer Schulz; Henrique Girao; Brenda R Kwak; Diego De Stefani; Rosario Rizzuto; Paolo Bernardi; Fabio Di Lisa
Journal:  J Cell Mol Med       Date:  2020-06-03       Impact factor: 5.310

Review 8.  The Functions, Methods, and Mobility of Mitochondrial Transfer Between Cells.

Authors:  Yiming Qin; Xin Jiang; Qi Yang; Jiaqi Zhao; Qiong Zhou; Yanhong Zhou
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

Review 9.  Connexins and Nitric Oxide Inside and Outside Mitochondria: Significance for Cardiac Protection and Adaptation.

Authors:  Maria Shvedova; Yana Anfinogenova; Sergey V Popov; Dmitriy N Atochin
Journal:  Front Physiol       Date:  2018-05-16       Impact factor: 4.566

Review 10.  An overview of protective strategies against ischemia/reperfusion injury: The role of hyperbaric oxygen preconditioning.

Authors:  Ciprian Hentia; Alex Rizzato; Enrico Camporesi; Zhongjin Yang; Danina M Muntean; Dorel Săndesc; Gerardo Bosco
Journal:  Brain Behav       Date:  2018-03-30       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.